DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.
Saved in:
| Title: | DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. |
|---|---|
| Authors: | Graham LS; University of Colorado, Aurora, CO., Henderson NC; University of Michigan, Ann Arbor, MI., Kellezi O; University of Michigan, Ann Arbor, MI., Hwang C; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Cancer Institute, Detroit, MI., Barata PC; University Hospitals Seidman Cancer Center, Cleveland, OH., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA., Kilari D; Department of Medicine, Clinical Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Pierro M; Department of Medicine, Clinical Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Thapa B; Department of Medicine, Clinical Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Tripathi A; Stephenson Cancer Center, Oklahoma City, OK., Mo G; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA., Labriola M; Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC., Park JJ; Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC., Rothstein S; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Garje R; Miami Cancer Institute, Baptist Health South Florida, Miami, FL., Koshkin VS; Division of Hematology and Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA., Patel VG; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Dorff T; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA., Armstrong AJ; Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC., McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA., Alva A; University of Michigan, Ann Arbor, MI., Schweizer MT; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2024 Aug; Vol. 8, pp. e2400014. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
